Frontiers in Microbiology (Apr 2020)

Multi-Label Random Forest Model for Tuberculosis Drug Resistance Classification and Mutation Ranking

  • Samaneh Kouchaki,
  • Yang Yang,
  • Yang Yang,
  • Alexander Lachapelle,
  • Timothy M. Walker,
  • Timothy M. Walker,
  • Timothy M. Walker,
  • A. Sarah Walker,
  • A. Sarah Walker,
  • A. Sarah Walker,
  • CRyPTIC Consortium,
  • Timothy E. A. Peto,
  • Timothy E. A. Peto,
  • Timothy E. A. Peto,
  • Derrick W. Crook,
  • Derrick W. Crook,
  • Derrick W. Crook,
  • David A. Clifton

DOI
https://doi.org/10.3389/fmicb.2020.00667
Journal volume & issue
Vol. 11

Abstract

Read online

Resistance prediction and mutation ranking are important tasks in the analysis of Tuberculosis sequence data. Due to standard regimens for the use of first-line antibiotics, resistance co-occurrence, in which samples are resistant to multiple drugs, is common. Analysing all drugs simultaneously should therefore enable patterns reflecting resistance co-occurrence to be exploited for resistance prediction. Here, multi-label random forest (MLRF) models are compared with single-label random forest (SLRF) for both predicting phenotypic resistance from whole genome sequences and identifying important mutations for better prediction of four first-line drugs in a dataset of 13402 Mycobacterium tuberculosis isolates. Results confirmed that MLRFs can improve performance compared to conventional clinical methods (by 18.10%) and SLRFs (by 0.91%). In addition, we identified a list of candidate mutations that are important for resistance prediction or that are related to resistance co-occurrence. Moreover, we found that retraining our analysis to a subset of top-ranked mutations was sufficient to achieve satisfactory performance. The source code can be found at http://www.robots.ox.ac.uk/~davidc/code.php.

Keywords